The recent spread of Zika virus (ZIKV) in the Americas and the Pacific has reached alarming levels in more than 60 countries. However, relatively little is known about the disease on a virological and epidemiological level and its consequences for humans. Accordingly, a large demand for in vitro derived Brazilian ZIKV material to support in vitro and in vivo studies has arisen. However, a prompt supply of ZIKV and ZIKV antigens cannot be guaranteed as the production of this virus typically using Vero or C6/36 cell lines remains challenging.
Introduction
Zika virus (ZIKV) is an arthropod-borne, enveloped virus belonging to the Flaviviridae family and the flavivirus genus. This family encompasses more than 75 single-stranded RNA viruses like Yellow fever virus, Japanese Encephalitis virus, West Nile virus and Dengue virus. These viruses are primarily transmitted by Aedes mosquitoes. In addition, sexual transmission seems likely based on clinical and serologic evidence [1] . Sporadic infections of humans with ZIKV have been reported in Africa from 1952 onwards, and circulation of the virus has resulted in natural population immunity over time. Therefore, observed progression of disease was rather mild or, due to low frequency and missing documentation, misinterpreted [2] . In contrast, the ZIKV outbreak in the Americas spread rapidly over the continent and has been accompanied by associated cases of microcephaly and GuillainBarré syndrome [3, 4] . Limited information regarding ZIKV disease, the association to fetal malfunctions and the lack of preventive or therapeutic tools prompted the World Health Organization (WHO) to declare it a global health emergency [5] . At present, the transmission of ZIKV and the mechanisms underlying ZIKV-related microcephaly and other neurodevelopment defects remain poorly understood and higher quantities of in vitro virus material should be produced as fast as possible to establish quantitative assays and to enable more comprehensive virological and immunological studies [6] . Current strategies for propagation of African and Brazilian ZIKV in animal cells mainly rely on Vero (kidney fibroblasts from African green monkey) cells and mosquito C6/36 (Ae. albopictus larvae) cells. The African ZIKV strain MR 766 has shown reasonable titers in both cells, whereas Brazilian ZIKV isolates from the current outbreak do not seem to propagate in similar quantities applying standard infection protocols (personal communication, A. Tanuri). Vero cells have an extraordinary safety profile and are widely used as an approved substrate for the production of human viral vaccines at commercial scale [7] , whereas lineages of the mosquito C6/36 cell line have been used only in fundamental research involving arboviruses [8] . However, both anchorage-dependent cell lines are difficult regarding large scale vaccine manufacturing as trypsinization is required for scale-up and passaging. Accordingly, the identification of a suspension cell line capable of producing reasonable virus titers would be a significant contribution towards establishment of a platform for ZIKV vaccine manufacturing.
In this study, we investigated Brazilian ZIKV replication in Vero and BHK-21 (kidney fibroblasts from Syrian baby hamsters) cells to develop a lab-scale process for the production of virus material in quantities required for the establishment of assays and virological studies. Therefore, we have adapted adherent BHK-21 cells to growth in a chemically defined (CD) medium and suspension. This enabled the scale-up into perfused and controlled stirred tank bioreactors to achieve high cell concentrations and reasonable virus yields even in the case low cell-specific yields cannot be avoided.
Materials and methods

Cell lines and cultivation conditions
Vero E6 cells (ATCC Ò CRL-1586 TM ) were maintained in tissue culture flasks with DMEM (high glucose, Gibco, USA, #11965092) and 5% fetal bovine serum (Sigma, USA, #F7524). Porcine kidney stable epithelial (PS) cells (thankfully provided by M. Niedrig, RobertKoch Institute, Germany) were used for the plaque assay and were grown in GMEM (Gibco, USA, #22100093) containing 10% fetal bovine serum, 2% FMV Peptone (LaB-M, UK, #MC033), 2 mM Lglutamine and 2 mM pyruvate (hereafter referred to as ZMedium). BHK-21 C13 cells (kindly provided by IDT Biologika GmbH, Germany) were initially cultivated in Z-Medium, but then step-wise adapted to suspension growth in the CD medium TCX6D or in equal volumes of TCX6D with TC-LECC medium (Xell AG, Germany), both supplemented with 8 mM L-glutamine. The basal growth medium TCX6D/TC-LECC for the perfusion run was additionally supplemented with 100 IU/mL Pen-Strep (Gibco, USA, #15140148). The adapted BHK-21 SUS cells were cultivated in spin-tubes with vented caps (TPP Sigma-Aldrich, USA, #Z761028) at 40 degree angle or in baffled shake flasks using an orbital shaker with 25 mm shaking diameter at 200 rpm (Celltron, Infors AG, Switzerland). [9] ). Plaques were counted and titers expressed as plaque-forming units per volume (PFU/mL) in accordance to Spearman and Kärber [10] . Intra-and extracellular viral RNA (vRNA) levels were determined by quantitative reverse transcription PCR (RT-qPCR). In brief, intact suspension cells were centrifuged at 200g for 5 min.
Zika virus propagation
The supernatant was used for extracellular vRNA quantification. The cell pellet was washed once with PBS to remove remaining extracellular virus and re-suspended in fresh PBS. Intracellular vRNA was released into the supernatant by three freeze/thawcycles of the re-suspended cells. After an additional centrifugation step at 2000g for 3 min, cell debris was removed and the supernatant containing intracellular vRNA was further processed. Intra-and extracellular vRNA molecules were extracted with QIAmp MiniElute Virus Spin (Qiagen, Netherlands, #57704) following the manufacturer's protocol. A set of primers and a probe specific for the E protein of ZIKV (previously described in [11] ) was used with One-Step TaqMan RT-PCR Master mix reagents (Applied Biosystems, USA, #4309169). Quantification was performed with a 7500 Real-Time PCR System (Applied Biosystems) following the manufacturer's recommendations.
Perfusion cultivation in 3 L single-use bioreactors
Cultivation was performed in a perfusion bioreactor system using a disposable Mobius Ò 3 L stirred tank vessel (Merck Millipore, USA, #CR0003L200), an ez-control unit (Applikon, Netherlands), and an alternating tangential flow filtration system (Xcell ATF 2, Repligen, USA). pH and dissolved oxygen (DO) probes as well as the perfusion dip-tube with pump housing and PES hollow fiber filter (0.2 lm pore size, 1 mm ID, 0.13 m 2 surface area, Repligen, USA, #F2:RF02PES) were autoclaved and connected under sterile conditions to the bioreactor vessel. The cultivation was performed in 1.2 L working volume (wv) at a stirrer speed of 120 rpm (pre-configured marine impeller) and a DO set-point of 80% air saturation maintained by pulsed sparging with pure oxygen and a maximum flow rate of 0.1 L/min. The ATF module was started with pump parameters, set points and process ranges as given by the supplier before inoculation to ensure homogenous cultivation conditions. BHK-21 SUS were inoculated at a starting concentration of 7 Â 10 5 cells/mL. At day 5, 0.7 reactor volumes (RV) were exchanged with basal growth medium to avoid depletion of media components. Afterwards, continuous perfusion of medium was started with supplemented perfusion medium (1:1 TCX6D/TC-LECC; 16 mM L-glutamine and 1Â MEM non-essential amino acids solution, Gibco, USA, #11140050) at a daily RV exchange rate (RV/ d) of 0.15 and increased to 0.42 at the end of cultivation to maintain glucose concentrations above 5 mM. When a cell concentration of about 1.2 Â 10 7 cells/mL was obtained, perfusion was stopped and 30% of the cell-free medium was removed through the hollow fiber filter. Subsequently, concentrated cells were infected with ZIKV PE at an MOI of 0.001 with periodic stirring (3 min on, 15 min off) to facilitate virus infection of cells. After 1 h virus adsorption, the stirrer was set back to 120 rpm and the bioreactor was filled up with fresh basal growth medium to the initial working volume. Perfusion was switched on after 3 h (0.15 RV/ d) to keep glucose concentrations above 5 mM, while pH was maintained at 7.1 by adding 0.5 M NaOH until the end of the process to maintain optimal cell growth conditions and to reduce pHinduced virus inactivation.
Sampling and analytics
Cell concentration and cell viability for spin-tube and shake flask experiments were determined by Muse Cell Analyzer with Count & Viability Assay Kit (both Merck Millipore, USA, #MCH100102). Same data for bioreactor cultivations were determined by manual trypan blue staining and counting using an optical microscope and a hemocytometer. Glucose concentrations were measured with measurements strips (Accu-Chek Active, Roche, Switzerland, #GG03149574).
Results
Brazilian ZIKV isolates differ strongly in virus yields
To characterize the replication of different Brazilian ZIKV strains, virus titers and cell-specific yields were determined in adherent BHK-21 and Vero cells (Table 1 ). For both cell lines, the maximum virus titers and the cell-specific yields were in the same order of magnitude. In contrast, the different virus isolates varied significantly in their titers. For example, in adherent BHK-21 cells, the maximum titer varied in the range of 4.1 Â 10 5 PFU/mL to 1.3 Â 10 7 PFU/mL, and the cell-specific yields from 1 to 41 PFU/cell.
A similar variation was observed for the adherent Vero cells. Clearly, in this direct comparison, the best yields for BHK-21 cells were obtained with ZIKV PE , which makes this virus-host cell system a candidate for virus production.
Restricted virus propagation in BHK-21 SUS cells
To study ZIKV replication in suspension cells, BHK-21 cells were adapted to a CD medium and to surface-independent growth (suspension). Subsequent infection studies in small scale spin-tubes following a factorial experimental design enabled the identification of optimal infection parameters. Highest virus titers of ZIKV ES isolates were obtained for infections at mid/late exponential cell growth phase (data not shown), whereas changes in MOI only had a minor impact on maximum yields (Fig. S1) . Accordingly, an MOI of 0.001 was chosen for all subsequent experiments. When BHK-21 SUS cells were infected after three days, cells grew exponentially with a population doubling time (t D ) of 25 h which strongly decreased to a t D of 125 h after infection (Fig. 1, left) . The infection experiment resulted in a maximum concentration of 7.1 Â 10 6 -cells/mL and a maximum virus titers not exceeding 9 Â 10 3 PFU/ mL (80 h post infection).
To further investigate the low ZIKV propagation in BHK-21 SUS cells, intra-and extracellular vRNA levels were measured by RTqPCR to identify potential bottlenecks in virus release (Fig. 1, right) . The linear correlation of extracellular cycle threshold (c T ) values to infectious titers in the supernatant determined by plaque assay cell. Previous experiments showed that the maximum virus yields were independent from the chosen MOI (as indicated in Fig. S1 ). We therefore assume the present infection study as comparable in its results. ( Fig. S2 ) enabled the interpretation of intracellular vRNA levels and the relative retention of virus material. Within one day, c T values of the intracellular vRNA levels dropped significantly (indication of successful virus entry and vRNA synthesis in BHK-21 SUS cells) and started to increase over the virus propagation phase again (decrease of intracellular vRNA levels). When the maximum virus titer of 9 Â 10 3 PFU/mL in the supernatant was measured (80 h post infection), the intracellular RNA level was about 2000-fold higher than the extracellular level (its c T value was lower), indicating non-optimal virus release.
Higher cell density cultivations
With the low cell-specific virus yields obtained for BHK-21 SUS cells in shake flasks, very large volumes would be required to produce larger quantities of ZIKV material. To overcome this limitation, perfusion cultivation using an ATF2 system was established to achieve higher cell concentrations in a next step. Cells grew within eight days to a maximum concentration of 1.2 Â 10 7 cells/ mL and reached an average t D of 84 h (Fig. 2) . To avoid limitations in glucose concentration, 0.7 reactor volumes were withdrawn five days after inoculation and replaced by fresh basal medium. Afterwards, a continuous medium exchange was initiated and low perfusion rates (8-21 mL/h) were sufficient to maintain the glucose concentrations above 5 mM. Prior to infection at day 8, BHK-21 SUS cells were concentrated in the bioreactor and subsequently infected with ZIKV PE at an MOI of 0.001 as described above. During the following two days, the cell concentration remained stable at 10.5 Â 10 7 cells/mL before concentrations dropped significantly due to virus-induced cell lysis. A maximum virus titer of 3.9 Â 10 7 PFU/mL was achieved four days post infection. Based on the maximum cell concentration at time of infection, this corresponded to a cell-specific virus yield of 3.3 PFU/cell. A total volume of 3.5 L medium was used for the perfusion over the period of 9.5 days. The cut-off of the filter membrane (200 nm) used was considerably larger than a ZIKV particle (50 nm), but only 23% of the virus concentration passed the filter at the maximum. When the highest titer was achieved at day four post infection, titers of 7 Â 10 6 PFU/mL were observed in the permeate relating to 20% of the virus concentration in the bioreactor. The low permeate flow rate resulted in an infectious virus loss of 4%. Towards the end of the cultivation, the RV/d was increased to 0.42, and viral titers in the permeate dropped to 4.5 Â 10 4 PFU/mL (data not shown).
Discussion
ZIKV and their yields in animal cell culture
Current ZIKV propagation protocols typically rely on adherent Vero and C6/36 insect cells. In this study, adherent BHK-21 and Vero cells showed similar yields for the four Brazilian virus isolates tested. However, the maximum virus yields varied by two orders of magnitude, indicating a strong influence driven by their different origins and histories (patient, region, passage history). Notably, our results suggest that isolates have to be chosen carefully for the production of larger virus amounts for assay development and clinical studies. Besides their immunogenic properties, host cell system and cell-specific yields need to be evaluated critically regarding the design of production processes. Further adaptation of virus isolates, identification of optimal infection conditions, and choice of media may allow to further improve yields of current ZIKV strains. Deeper understanding may derive from genome sequencing of different isolates to reveal the linkage of mutations and their impact on their replication in cell culture.
ZIKV propagation in BHK-21 SUS cells
BHK-21 SUS cells showed low doubling times of 25 h achieving concentrations more than 7 Â 10 6 cells/mL in shake flasks and simple batch mode. In addition, they are easy to handle in orbitally shaken or mechanically stirred cultivation vessels, which makes them an ideal candidate for large scale production. Infection studies with the best performing ZIKV PE isolate, however, showed significantly reduced cell-specific yields compared to adherent BHK-21 cells. This may be ascribed to both, differences in media composition (lack of serum) and in cell morphology (anchorageindependent cell maintenance). However, as the chosen CD medium does not support adherent cell growth, this cannot be further explored. To overcome the low virus titers in BHK-21 SUS cells cultivated in CD medium, first experiments focused on the improvement of virus adsorption in suspension culture. Hence infections were performed by centrifugal spinoculation [12] , high MOI (>5) or in decreased cultivation volumes at time of infection. However, none of these approaches resulted in significant improvements (Fig. S3) . To follow-up on a possible assumption of non-optimal virus maturation and virus release in BHK-21 SUS cells, RT-qPCR was used to evaluate vRNA levels. At the time point maximum titers were achieved (80 h post infection), the intracellular number of vRNA molecules was 2000-fold higher than in the supernatant, which may be related to poor virus release and low extracellular viral titers. This finding is in agreement with transmission electron microscopic observations, where ZIKV was identified to remain in cellular vesicles inside adherent Vero cells [13] . In addition, it is not clear, whether all cells were infected and contributed to virus yields. Further studies using flow cytometry and staining of viral antigens should help to answer these critical questions regarding process design and optimization [14] .
ZIKV PE titers in the perfusion bioreactor
One strategy to overcome process limitations due to low cellspecific virus yields is process intensification by increased cell concentrations. Thus, BHK-21 SUS cells were maintained in a bioreactor coupled to an ATF2 cell retention system. Controlled process parameters and continuous medium exchange enabled cell concentrations of up to 1. the average doubling time (84 h) was lower compared to a 3 L Applikon glass bioreactor and non-controlled shake flasks (50 h and 25 h, respectively, Fig. S4 ). However, it has to be taken into account that perfusion experiments with the Mobius system had to be carried out under BSL-3 conditions and that limited possibilities of monitoring metabolite concentrations may have resulted in suboptimal cell growth. Nevertheless, within four days virus titers increased significantly to 3.9 Â 10 7 PFU/mL in the perfusion bioreactor. Although the cell-specific yield (3.3 PFU/cell) was about 10-times lower in comparison to adherent BHK-21 cells, the controlled cultivation clearly improved total virus production and one cultivation in the ATF system could replace more than 90 tissue culture flasks with 175 cm 2 and 40 mL wv each (3.6 L in total). Despite the slow-lytic nature of flavivirus release, a sharp drop in cell concentration was observed two days post infection. This may have enabled the release of viral particles so that further infections were initiated. Furthermore, maintaining optimal cultivation conditions might have positively influenced the cell status for virus replication and stable pH values at 7.1 might have supported pHdepended virus maturation and diminished virus inactivation [15] so that high virus titers were achieved. However, the drop in cell-specific yields in comparison to adherent cells remains unclear. Although a filter membrane with 200 nm cut-off was chosen, only a small fraction of ZIKV particles (50 nm) migrated through the filter. One day post infection, 20% of the virus concentration in the bioreactor was found in the permeate flow and strongly decreased to less than 1% to the end of the cultivation. Similar results were previously obtained for influenza virus [16] . Details about unspecific virus adsorption onto the filter membrane or membrane clogging remain to be investigated. Future studies with different filter cut-offs, virus retention or virus harvest strategies with membrane stacks could be equally considered to design production processes.
Use of BHK-21 cells for human vaccine production
Continuous adherent BHK-21 C13 cells are well-known for their robust cell growth, their adaptability towards suspension growth and high cell densities. The cultivation of BHK-21 in suspension culture and their susceptibility for various virus families enables large scale manufacturing of veterinary vaccines at affordable prices, like rabies vaccines [17] and foot and mouth disease vaccines [18] . Additionally, BHK-21 cells are used in the industrial production of recombinant biopharmaceuticals, such as human FVIII and FVIIa, and is therefore considered as a well-characterized cell substrate by the WHO [19] . Despite the long history of success, the use of BHK-21 cells for human vaccine production is highly controversial as intact cells have been classified tumorigenic almost 40 years ago [20] . However, with the significant advances made in downstream processing regarding the depletions of DNA and host cell proteins, continuous cell lines, such as BHK-21 cells, should not necessarily be excluded for vaccine production purpose anymore [19] . Clinical studies of an inactivated BHK-derived rabies vaccine in humans showed great efficacy and a satisfactory safety profile [21, 22] . Before the acceptance and establishment of BHK-21 as cell substrate for human vaccine production, it will require further costly purity, safety and consistency studies [19] , but over the long run advantages such as high permissivity for many virus families, high productivity, robustness, and fast growth to high concentrations in suspension culture may turn these studies commercially attractive. For the meanwhile, virus material produced in adherent or suspension BHK-21 cells could be used to deliver enough ZIKV material for assay development as well as virological and epidemiological studies.
Conclusions
Current cell-culture based ZIKV production relies on Vero and C6/36 cell lines. However, the surface-dependent growth of both cell lines and the low cell-specific yields of Brazilian ZIKV isolates limit the establishment of large scale production processes to provide virus material for assay development and scientific studies. We have infected adherent BHK-21 and Vero cells with different Brazilian ZIKV isolates and observed that cell-specific virus yields were independent from the host cell. However, besides this intrinsic consistency of each isolate, virus titers strongly varied between different ZIKV isolates. This led to the identification of a high producer virus isolate, namely ZIKV PE . Infection studies of BHK-21 SUS cells with ZIKV PE indicated possible limitations in virus release observed by accumulation of intracellular vRNA molecules. Higher virus yields were obtained by the use of a perfusion bioreactor that enabled a significant increase in cell concentrations. The characterization of intracellular virus replication and virus spreading using flow cytometry as well as the optimization of infection conditions, media, and cultivation conditions will help to identify bottlenecks in virus production and support the design of improved production processes.
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